Ontology highlight
ABSTRACT: Objective
Most patients suffering with rheumatic diseases who undergo surgical treatment are receiving immune-modulating therapy. To determine whether these medications affect their outcomes a national registry was established in Germany by the German Society of Surgery (DGORh). Data from the first 1000 patients were used in a pilot study to identify relevant corisk factors and to determine whether such a registry is suitable for developing accurate and relevant recommendations.Design and participants
Data were collected from patients undergoing surgical treatments with their written consent. A second consent form was used, if complications occurred. During this pilot study, in order to obtain a quicker overview, risk factors were considered only in patients with complicati
SUBMITTER: Kostuj T
PROVIDER: S-EPMC5640080 | biostudies-literature | 2017 Oct
REPOSITORIES: biostudies-literature